Infectious agents develop intricate mechanisms to interact with host cell pathways and hijack their genetic and epigenetic machinery to change host cell phenotypic states. Among the Apicomplexa phylum of obligate intracellular parasites, which cause veterinary and human diseases, Theileria is the only genus that transforms its mammalian host cells 1 . Theileria infection of bovine leukocytes induces proliferative and invasive phenotypes associated with activated signalling pathways, notably JNK and AP-1 (ref. 2) . The transformed phenotypes are reversed by treatment with the theilericidal drug buparvaquone 3 . We used comparative genomics to identify a homologue of the peptidyl-prolyl isomerase PIN1 in T. annulata (TaPIN1) that is secreted into the host cell and modulates oncogenic signalling pathways. Here we show that TaPIN1 is a bona fide prolyl isomerase and that it interacts with the host ubiquitin ligase FBW7, leading to its degradation and subsequent stabilization of c-JUN, which promotes transformation. We performed in vitro and in silico analysis and in vivo zebrafish xenograft experiments to demonstrate that TaPIN1 is directly inhibited by the anti-parasite drug buparvaquone (and other known PIN1 inhibitors) and is mutated in a drug-resistant strain. Prolyl isomerization is thus a conserved mechanism that is important in cancer and is used by Theileria parasites to manipulate host oncogenic signalling.
To identify proteins secreted by Theileria into the host cell that could contribute to transformation [4] [5] [6] , we conducted an in silico screen of parasite genomes; we identified 689 proteins in the T. annulata genome with a predicted signal peptide. Comparison with the T. gondii (a nontransforming apicomplexan parasite) proteome narrowed the candidate list to 33 proteins with a Theileria-specific signal peptide (Extended Data Fig. 1a ). We focused on the TA18945 gene encoding a homologue of the human parvulin PIN1 (hPIN1) peptidyl-prolyl isomerase (PPIase), as mammalian PIN1 regulates cell proliferation, pluripotency and survival 7, 8 , and contributes to tumorigenesis 9, 10 . hPIN1 catalyses the cis/ trans isomerization of peptidyl-prolyl bonds in phosphorylated Ser/ Thr-Pro motifs, inducing conformational changes that affect substrate stability and activity 11, 12 , and there are several small-molecule inhibitors of hPIN1 (refs 13-15) . The TA18945-encoded protein has a signal peptide and a highly conserved PPIase domain (Extended Data Fig. 1b, c) , but lacks the WW domain important for substrate recognition of mammalian PIN1 (ref. 11) . A gene in the T. parva genome, also associated with transformation, encodes a conserved TpPIN1 predicted protein, whereas the signal peptide is not conserved in the related T. orientalis genome, which does not transform host cells 16 (Extended Data Fig. 2a, b ). We detected Theileria pin1 transcripts in B cells infected with T. annulata or T. parva, and they decreased upon buparvaquone treatment (Fig. 1a ). The levels of host bovine BtPin1 transcripts were unaffected by Theileria infection or buparvaquone treatment (Extended Data Fig. 3 ). An antibody generated against a TaPIN1-specific peptide (NPVNRN TGMAVTR) recognized parasite PIN1 protein or transfected TaPIN1 in mouse fibroblasts, but not mammalian PIN1 ( Fig. 1b and Extended Data Fig. 4a-e ). Confocal microscopy and immunoblot analysis located the parasite PIN1 protein to both the host cell cytoplasm and nucleus (Fig. 1b, c and Extended Data Fig. 4c, d) . The host nuclear signal in the confocal images was tenfold over background in parasitized cells (205.0 6 15.48 nuclear fluorescence intensity per pixel compared with 21.45 6 8.50 in controls, P , 0.0001, n 5 31). Thus, comparative parasite genomics identified TaPIN1, which is secreted into the host cytoplasm and nucleus. To explore the functional PPIase activity of the secreted TaPIN1 protein, we developed a chymotrypsin-coupled in vitro assay and found that TaPIN1 and hPIN1 catalytic activities were comparable ( Fig. 2a ). TaPIN1 and hPIN1 were also equivalent in activation of the cyclin D1luciferase reporter in bovine B cells ( Fig. 2b) , an established readout for PIN1 activity 9 . We mutated key C92 and K38 residues in TaPIN1 and showed loss of the PPIase activity ( Fig. 2c ). Furthermore, TaPIN1 rescued cyclin D1 promoter activity and cell spreading defects in Pin1 2/2 mouse fibroblasts ( Fig. 2d and Extended Data Fig. 5a ). Mammalian PIN1 overexpression disrupts cell cycle regulation, causing centrosome amplification and cell transformation 17 . TaPIN1 also induced centrosome duplication when overexpressed in mouse fibroblasts ( Fig. 2e and Extended Data Fig. 5b ). Furthermore, TaPIN1 functionally replaced mammalian PIN1 and rescued colony formation as effectively as hPIN1 in human breast cancer cells with knocked-down PIN1 (Fig. 2f ). These combined results show that Theileria secretes a bona fide phosphorylationdependent PPIase that could contribute to host cell transformation.
In a search for potential inhibitors, we noted that the chemical structure of buparvaquone is similar to juglone, a well characterized inhibitor of mammalian PIN1 (ref. 13) . The TaPIN1 sequence exhibits over 47% identity with hPIN1 in the PPIase domain (Extended Data Fig. 6a ). Our homology models of TaPIN1 protein, based on published hPIN1 experimental data, suggest a similar structure with a conserved catalytic pocket ( Fig. 3a and Extended Data Fig. 6b ). Notably, several PIN1 homologues also lack the WW domain, including Arabidopsis thaliana AtPIN1 18-20 , MdPIN1 in Malus domestica and the parasite Trypanosoma brucei TbPIN1 homologue [20] [21] [22] , and the predicted TaPIN1 model closely resembles these structures (Extended Data Fig. 6d ). We investigated the hPIN1 experimental structure and the TaPIN1 predicted model with the binding pocket and hotspot detection algorithm FTMap, using the server FTFlex. Notably, we found key hotspot regions in the catalytic site area, matching the substrate-binding region of hPIN1 (Extended Data Fig. 6 ). Juglone and buparvaquone molecules could be docked into the active site of both TaPIN1 and hPIN1 using in silico approaches ( Fig. 3a and Extended Data Fig. 6c ). We predicted that buparvaquone might target TaPIN1 directly and that juglone (or other PIN1 inhibitors) could functionally replace buparvaquone to block parasite transformation. Both buparvaquone and juglone inhibited TaPIN1 PPIase activity in vitro, as did the unrelated non-quinone inhibitor dipentamethylene thiuram monosulphide (DTM) 14 , albeit to a lesser degree ( Fig. 3b ). Buparvaquone-resistant Theileria strains are an emerging clinical concern for cattle in infected areas 23 and mutations in the cytochrome b gene were recently reported 24 . But mitochondrial and non-mitochondrial pathways might cooperate in transformation and participate in drug resistance. We sequenced the Tapin1 gene in genomic DNA from a drug-resistant isolate and identified a mutation (A53 . P substitution) in the catalytic loop of TaPIN1 (Extended Data Fig. 7 ). Structural modelling suggested that this mutation could affect the nearby catalytic region and disturb ligand binding; computational docking indicated that the small juglone molecule could react with the thiolate group of C113 or C92 in hPIN1, TaPIN1 or mutant TaPIN1(A53P). However, the A53P mutation might impede interaction with the bulky, hydrophobic moiety of the larger buparvaquone compound (molecular weight (MW) 5 326 Da, compared with juglone MW 5 176 Da), creating steric clashes between the inhibitor and residues in the modified structure ( Fig. 3a and Extended Data Fig. 6c ). Mutant TaPIN1(A53P) was catalytically active on the PIN1 substrate and was inhibited by juglone and DTM, but not by buparvaquone ( Fig. 3b ). The PIN1 inhibitors (buparvaquone, juglone and DTM) all reduced parasite load and viability of host cells infected with T. annulata or T. parva (Fig. 3c , d and Extended Data Fig. 8a ) and blocked colony growth of parasitized cells in soft-agar assays in vitro ( Fig. 3e and Extended Data Fig. 8b ). In contrast, knocking down the endogenous bovine BtPin1 did not affect colony formation (Extended Data Fig. 8c ). Transfection with mutant TaPIN1(A53P) rendered TBL3 cells resistant to buparvaquone, but not juglone, treatment (Extended Data Fig. 8d ). Similarly, juglone inhibited both wild-type and mutant TaPIN1 activity in the cyclin D1luciferase assay, but only the mutant was resistant to buparvaquone (Extended Data Fig. 8e ). Fish xenograft models are effective for monitoring in vivo tumour formation and for drug testing 25 , and are emerging as important experimental models to study cancer 26 . We used a zebrafish xenograft experimental system to test drug effects on tumour growth in vivo and observed a twofold increase in tumour growth of infected cells that was efficiently inhibited by the anti-PIN1 drugs ( Fig. 3f, g) . Thus, our modelling predictions, biochemical analysis in vitro, transformation assays and tumour growth in vivo all support the targeting of TaPIN1 by buparvaquone and the role of TaPIN1 in Theileria-induced cell transformation.
To investigate how TaPIN1 affects host signalling pathways, we studied relevant substrates targeted by TaPIN1. hPIN1 targets many proteins, including the ubiquitin ligase FBW7 (ref. 27) , which exerts an antitumour function by degrading oncoproteins required for cellular proliferation, such as c-JUN 28, 29 . Since c-JUN is induced (and critical) during Theileria-induced transformation 2 , we examined whether TaPIN1 targets the conserved bovine FBW7 protein. We found that TaPIN1 interacts 
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G2015 Macmillan Publishers Limited. All rights reserved with host FBW7 in Theileria-infected cells or murine fibroblasts (Extended Data Fig. 9a, b ). Conversely, FBW7a in particular, but not other isoforms, co-immunoprecipitated TaPIN1 from parasitized cells ( Fig. 4a ). FBW7a protein levels were reduced in parasitized cells compared with uninfected cells and correlated with elevated c-JUN levels (Fig. 4b ).
Pharmacological TaPIN1 inhibition restored FBW7 protein expression and reduced c-JUN levels, without affecting messenger RNA expression ( Fig. 4b and Extended Data Fig. 9c, d ). But knocking down BtPIN1 did not affect FBW7 or c-JUN protein levels (Extended Data Fig. 9e ). Short interfering RNA (siRNA) knockdown of FBW7 caused accumulation of c-JUN protein, whereas exogenous FBW7a transfection decreased c-JUN protein levels ( Fig. 4c ). Furthermore, knocking down FBW7 increased AP-1 activity, as measured by a luciferase reporter assay, and rescued the inhibition of AP-1 by buparvaquone or juglone ( Fig. 4d, e ). TaPIN1 inhibition caused increased c-JUN ubiquitination in TBL3 cells and decreased FBW7 (auto)-ubiquitination (Extended Data Fig. 9f ). c-JUN ubiquitination was FBW7-dependent, as this effect was abolished by siRNA targeting bovine Fbw7 (Fig. 4f ). Half-life analysis using cycloheximide showed that siFbw7 increased c-JUN stability and rescued c-JUN levels after TaPIN1 inhibition (Fig. 4g ). In addition, the TaPIN1 (A53P) mutant rescued the effect of buparvaquone, but not juglone, on c-JUN ubiquitination and transcriptional activity (reflected by the expression of bovine Mmp-9, an AP-1 target gene) (Extended Data Figs 8f and 9g). As mammalian FBW7 targets many protein substrates, we examined the effects of buparvaquone treatment or FBW7a transfection, but noted no changes in levels of endogenous c-MYC or activated NOTCH1 proteins, while there was a modest effect on the KLF5 transcription factor (Extended Data Fig. 9h , i). These combined results suggest that c-JUN is the major target of TaPIN1-FBW7a in parasitized cells. Finally, FBW7a overexpression or c-JUN knockdown both caused a significant reduction of colony growth in soft-agar proliferation assays of parasitized TBL3 cells (Fig. 4h ). c-JUN is critical for Theileria transformation and host cell proliferation 2 , but it was previously unknown how the parasite initiated this effect. In TBL3 cells, c-JUN seems to be activated by reduced FBW7 degradation rather than phosphorylation by JNK signalling 2 . Subsequent activation of a feedback loop, involving c-JUN control of the microRNA miR-155 oncomiR, could create a epigenetic switch to maintain transformation and proliferation 30 . We studied B lymphocytes infected naturally with T. parva (TpMD409) or artificially with T. annulata (TBL3) . c-e, P values were corrected using the Dunnett test multiple comparisons with the control. f, An unpaired Mann-Whitney test was performed for the zebrafish experiments to analyse the significant differences between the control and treatment groups. *P , 0.05, **P , 0.01, ***P , 0.001. NS, not significant.
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and are currently investigating Theileria-transformed T lymphocytes and macrophages. Our discovery of mutation in the Tapin1 gene suggests that new anti-PIN1 compounds might be effective clinical reagents to treat drug-resistant theileriosis. Finally, the evolution of a PIN1 homologue with an acquired signal peptide only in T. annulata and T. parva genomes provides a fascinating insight into how apicomplexan species have hijacked oncogenic pathways to maintain host cell transformation.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. We measured the PPIase activity with the substrate (0.03 mg ml 21 , 50 mM) in the presence of chymotrypsin (0.2 mg ml 21 ) and GST-PPIases (25 nM) (pre-incubated or not with buparvaquone, juglone or DTM for 4 h at 4 uC) at 390 and 510 nm using a Flexstation III spectrophotometer. Implantation of cells in zebrafish embryos. The zebrafish experiments described in the present study were conducted at the University of Burgundy according to French and European Union guidelines for the handling of laboratory animals. The animal procedures carried out in this study were reviewed and approved by the local Ethics Committee ''Comité d'éthique de l'expérimentation animale Grand Campus Dijon'' (C2EA Grand Campus Dijon number 105). Adult wild-type (WIK, ZIRC, Oregon) zebrafish and embryos were raised, staged and maintained according to standard procedures at 28uC under a 14h: 10h light/dark cycle. Dechorionized 2 days post-fertilization zebrafish embryos were anaesthetized with 0.003% tricain (Sigma) and positioned on a 10 cm Petri dish before implantation. TBL3 or BL3 cells were treated for 24 h with DTM, buparvaquone or juglone, rinsed with PBS, labelled with the fluorescent cell tracker CM-DiI (Invitrogen) according to the manufacturer's instructions and resuspended in PBS. The cell suspensions were loaded into borosilicate glass capillary needles and the injections were performed using a microinjector (Femtojet, Eppendorf Optical sections were acquired every 320 nm. Image analysis and nucleus fluorescence intensity per pixel quantifications were performed using the software Imaris 6.7.5 (Bitplane). Quantifications were done on the whole nucleus of n 5 31 bovine infected or non-infected cells after three-dimensional construction and normalized to the background signal obtained after staining with the anti-rabbit secondary antibody alone. Analysis of centrosome duplication during S phase. Centrosome duplication assays in NIH/3T3 cells were conducted as described previously 17 Colony forming assay. MCF10A cells were transfected by the indicated plasmids using Fugene HD transfection system (Promega, ref: E2311) following the manufacturer's instructions. After 36 h, 1,000 cells were plated in 6-well plates. Cultures were incubated in humidified 37 uC incubators with an atmosphere of 5% CO 2 in air, and control plates were monitored for growth using a microscope. At the time of maximum foci formation (8-10 days in culture), final foci numbers were counted manually after fixation a staining with 0.5% Crystal Violet (Sigma, ref: C3886). Soft-agar colony forming assay. A two-layer soft-agar culture system was used. A total of 20,000 bovine cells (treated with buparvaquone or juglone) or 40,000 bovine cells (treated with DTM or transfected with indicated plasmids/siRNA) were plated in a volume of 1.5 ml (0.7% SeaKem ME Agarose; Lonza, ref: 50011) plus 23 DMEM 20% fetal calf Serum over a 1.5-ml base layer (1% SeaKem ME Agarose plus 23 DMEM 20% fetal calf Serum) in 6-well plates. Cultures were incubated in humidified 37 uC incubators with an atmosphere of 5% CO 2 in air, and control plates were monitored for growth using a microscope. At the time of maximum colony formation (10-15 days in culture), final colony numbers were counted manually after fixation a staining with 0.005% Crystal Violet (Sigma, ref: C3886).
GST pull-down. hPIN1, TaPIN1 wild type and TaPIN1(A53P) were cloned between restriction sites BamHI and EcoRI in pGEX-2T plasmid, which was provided by G. Del Sal. TaPIN1 wild type or A53P: forward, CGCGGATCCGCCCACTTG CTACTAAAG, reverse, CCGGAATTCTTATGCGATTCTATATATAAGATG. Plasmid constructs were expressed in E. coli strain BL21 and purified using glutathione-sepharose beads. Concentration of purified protein was estimated by Coomassie staining. Beads coated with 1 mg of GST fusion proteins were incubated with 250 ml of cell lysate (see later) in 50 mM Tris pH 7.6, 150 mM NaCl, 0.1% Triton, for 2 h at 4 uC. Beads were washed five times with 50 mM Tris pH 7.6, 300 mM NaCl, 0.5% Triton. Proteins were revealed by western blot analysis using specific antibodies. Immunoprecipitation with HA. NIH/3T3 cells stably expressing TaPIN1 or TBL3 cells transiently expressing the FBW7 constructs were lysed in the following buffer: 20 mM Tris HCl pH 8, 150 mM NaCl, 0.6% NP-40 and 2 mM EDTA. Protein complexes were affinity-purified on anti-HA antibody-conjugated agarose Bioinformatic screen. On 10 September 2011, search strategies at EuPathDB 32 were used to search for all T. annulata protein-encoding genes with predicted signal peptides (SignalP 2.0). Six-hundred and eighty-nine genes were returned. Onehundred and thirty-eight of these were found to have a predicted signal peptide only in T. annulata and not in their T. gondii orthologues. Among these proteins, we excluded (1) hypothetical proteins, (2) proteins that are not expressed at the macroschizont stage, and (3) proteins that are predicted to be targeted to the apicoplast of the parasite. We obtained 33 proteins, as shown in Extended Data Fig. 1a . This search strategy was repeated on 22 April 2013 to ensure that results were consistent with any EuPathDB updates. All 33 proteins from Extended Data Fig. 1a were returned in the updated search. Analysis of protein structures and docking computations. Homology models of TaPIN1 wild type and the A53P mutant were built with the online server EsyPred 33 . The experimental structure of hPIN1 (ref. 34) co-crystallized with a dipeptide Ala-Pro (resolution 1.35 Å ) was used as a template. To check the protonation state of the protein titratable groups, we used our online server PCE 35 . The most likely binding pocket areas for TaPIN1 wild type were predicted with FTMap and investigation of side-chain flexibility (if any) in the area of the predicted binding cavities was carried out with the server FTFlex 36 . The two-dimensional structures of juglone, buparvaquone and DTM were obtained from PubChem and the three-dimensional structures were generated with our package DG-AMMOS 37 . Three docking tools, Surflex 38 , Molegro Virtual Docker 39 and our tool MS-DOCK 40 , were used to search for possible poses of these compounds in hPIN1, for TaPIN1 wild type and the A53P mutant. Calibration of our docking tools was performed on the thiol-stress sensing regulator co-crystallized with a quinone molecule, which in this structure is covalently attached to a Cys residue (Protein Data Bank accession 4HQM) 41 .
Visualization was carried out with PyMol and figures were also prepared with this molecular viewer package.
Extended Data Figure 2 | TaPIN1 is conserved between T. annulata and T.
parva. a, As the T. parva TpPIN1 sequence did not have an annotated signal peptide, we reanalysed sequence alignment of pin1 genes in T. annulata (Tapin1) and T. parva (Tppin1) (National Center for Biotechnology Information (NCBI) BLAST). The annotated T. annulata intron is indicated in grey and the annotated methionine codon (ATG) in T. parva is in black (underlined). Tapin1 and Tppin1 are well conserved, including in the intronic sequence. We conclude that the T. parva Tppin1 annotation should be modified in light of our polymerase chain reaction (PCR) and western blot analysis (see Fig. 1b and Extended Data Fig. 5c ). b, Sequence alignment of pin1 genes in T. annulata (Tapin1) and T. orientalis (Topin1) (NCBI BLAST). The annotated T. annulata intron is indicated in grey and the annotated methionine codon in T. orientalis is in black (underlined). Tapin1 and Topin1 are less conserved than Tapin1 and Tppin1. 
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Extended Data Figure 6 | The PPIase domain of PIN1 is well conserved. a, Sequence alignment of PIN1 genes in H. sapiens, A. thaliana, T. brucei and T. annulata revealed the presence or the absence of a conserved WW domain. Percentages of identity are indicated. The magenta box indicates the predicted signal peptide of TaPIN1. b, Homology models for TaPIN1 wild type (WT) and the A53P mutant based on sequence identity/similarity with hPIN1. The Ala to Pro mutation in TaPIN1 appears to induce a conformational change within and nearby the catalytic loop. c, The buparvaquone molecule can be docked in the active site of hPIN1 or in the active site of the wild-type TaPIN1 predicted structure. Here, the second lowest docked energy pose is shown (the best predicted energy pose is shown Fig. 3a ). These two predicted binding poses are fully consistent with the different binding modes of some inhibitors co-crystallized with hPIN1. Yet, considering the computations shown in e, we suggest that the most likely pose for buparvaquone corresponds to pose 1, as reported in Fig. 3a . However, independently of the selected poses, we expect that buparvaquone would not fit well in the catalytic pocket due to structural changes induced by the A53P mutation. d, Three-dimensional structure of the experimental hPIN1 structure and the predicted TaPIN1 wild-type and A53P mutant structures, alongside Trypanosome TbPIN and Arabidopsis PIN1At models (ribbon diagram). The three-dimensional structures are well conserved among these proteins with some differences, for instance, in the catalytic loops. The TaPIN1, TbPIN1 and PIN1At enzymes lack the WW domain present in hPIN1 yet the overall fold in the catalytic area is well conserved, suggesting that accurate homology models for TaPIN1 can be built using the approach used here. e, The experimental structure of hPIN1 is represented as a solid surface with a view down the active site, showing a small co-crystallized ligand next to the catalytic site residue Cys 113. In the same orientation, small chemical fragments are predicted to bind in the catalytic site region with FTmap. Using this information, we propose that the most likely binding pose for buparvaquone is the one shown in Fig. 3 . 
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Extended Data Figure 8 | Inhibition of BtPin1 does not affect Theileriaassociated cell transformation. a, Buparvaquone (Bup), juglone (Jug) and DTM decreased the viability of cells infected with T. parva (TpMD409). Host cell viability was assessed using the XTT assay after 72 h. b, Colony formation of parasite-infected TpMD409 cells in soft agar was lost after 72 h treatment with buparvaquone, juglone or DTM. Numbers of macroscopic colonies per plate were counted after 10 days. c, siBtPin1 has no effect on TBL3 transformed phenotypes. TBL3 cells were transiently transfected with siControl or siBtPin1.
The average number of colonies per plate is shown (average 6 s.d., n 5 3). Indicated protein levels were detected by western blot analysis using specific antibodies. Actin was used as loading control (results are representative of three independent experiments). d-f, Overexpression of the TaPIN1 A53P mutant rescued the buparvaquone but not juglone effects on Theileria-infected cells. WT, wild type. All data represent three independent experiments (average 6 s.d., n 5 3). The SPSS 19.0 program was used for statistics. *P , 0.05, **P , 0.01. NS, not significant.
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